EZH2 and osteosarcoma: Consistent with the findings of EZH2 siRNA silencing in osteosarcoma cells in this study, treatment of osteosarcoma cell lines U2OS and SAOS with DZNep resulted in significant reduction of EZH2 protein levels and subsequently decrease H3K27me3 levels in a dose-dependent manner (Figure 6A).